June 23-30, 2016
Last Updated: Jun 23, 2016
- EMR Documentation of Physician-Patient Communication Following Genomic Counseling for Actionable Complex Disease and Pharmacogenomic Results.
Sweet Kevin et al. Clinical genetics 2016 Jun - Virtual Pharmacist: A Platform for Pharmacogenomics.
Cheng Ronghai et al. PloS one 2015 10(10) e0141105 - The frequency of SLCO1B1*5 polymorphism genotypes among Russian and Sakha (Yakutia) patients with hypercholesterolemia.
Sychev Dmitrij Alekseevitch, et al. Pharmacogenomics and personalized medicine 2016 0 59-63 - Phenome-wide association study maps new diseases to the human major histocompatibility complex region.
Liu Jixia, et al. Journal of medical genetics 2016 6 - Implementation of Electronic Consent at a Biobank: An Opportunity for Precision Medicine Research.
Boutin Natalie T et al. Journal of personalized medicine 2016 6(2) - Sequenom, the U.S. Supreme Court, and Personalized Medicine.
Kodroff Cathy A et al. Human gene therapy. Clinical development 2016 Jun - The financial hazard of personalized medicine and supportive care.
Carrera Pricivel M et al. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2015 Dec 23(12) 3399-401 - A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation Analysis.
Giladi Nir, et al. Frontiers in neurology 2016 0 71 - Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma.
Zhou Jun, et al. Oncotarget 2016 5 - Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kuo Ho-Chang, et al. PloS one 2016 0 (5) e0154943 - Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNF? biologic for ulcerative colitis: a case report.
Henderson Sara L, et al. BMC cancer 2016 0 304 - The Shift From Personalized Medicine to Precision Medicine and Precision Public Health: Words Matter!
MJ Khoury, CDC Blog Post, April 21, 2016 - Genetic data: The new challenge of personalized medicine, insights for rheumatoid arthritis patients.
Goulielmos George N et al. Gene 2016 Jun (2) 90-101 - Associations between PTPRC rs10919563 A/G and FCGR2A R131H polymorphisms and responsiveness to TNF blockers in rheumatoid arthritis: a meta-analysis.
Lee Young Ho, et al. Rheumatology international 2016 4 - Are behavioral practices for overcoming nature the hope for personalized medicine?
J Fernandez, AJCN< March 2016 - Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform
A Zarrinpar et al, Science Translational Medicine, April 7, 2016 - Comparative genomic analysis of primary tumors and metastases in breast cancer.
Bertucci François, et al. Oncotarget 2016 3 - Implementation of personalized medicine for fracture risk assessment in osteoporosis.
Mori Seijiro, et al. Geriatrics & gerontology international 2016 3 57-65 - Personalized medicine promises better treatment options for cystic fibrosis patients,
News-Medical.net, March 25, 2016 - Fluoropyrimidine and platinum toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.
Campbell Jared M, et al. Pharmacogenomics 2016 2 - Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia.
Nisenbaum Laura K, et al. Journal of personalized medicine 2016 0 (1) - The population genetics of pharmacogenomics VIP variants in the Sherpa population.
Wang Li, et al. Drug metabolism and pharmacokinetics 2015 12 - Prospective analysis of UGT1A1 promoter polymorphism for irinotecan dose escalation in metastatic colorectal cancer patients treated with bevacizumab plus FOLFIRI as the first-line setting: study protocol for a randomized controlled trial.
Yeh Yung-Sung, et al. Trials 2016 0 (1) 46 - Pharmacogenetics driving personalized medicine: analysis of genetic polymorphisms related to breast cancer medications in Italian isolated populations.
Cocca Massimiliano, et al. Journal of translational medicine 2016 0 (1) 22 - Analytical Validation of a Personalized Medicine APOL1 Genotyping Assay for Nondiabetic Chronic Kidney Disease Risk Assessment.
Zhang Jinglan, et al. The Journal of molecular diagnostics : JMD 2016 1 - Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.
Han Sang Won, et al. International journal of stroke : official journal of the International Stroke Society 2016 1 - Genetic polymorphisms and phenotypic analysis of drug-metabolizing enzyme CYP2C19 in a Li Chinese population.
Ding Yipeng, et al. International journal of clinical and experimental pathology 2015 0 (10) 13201-8 - Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.
He Yongjun, et al. International journal of clinical and experimental pathology 2015 0 (10) 13293-303 - Family Health History Education to Improve Genetic Risk Assessment[PDF 110.73 KB]
Disease: Lynch syndrome|Breast Cancer|Ovarian Cancer; Type: Program; State: California - P450 (Cytochrome) Oxidoreductase Gene (POR) Common Variant (POR*28) Significantly Alters CYP2C9 Activity in Swedish, But Not in Korean Healthy Subjects.
Hatta Fazleen H M, et al. Omics : a journal of integrative biology 2015 12 (12) 777-81
- Human (333)
- Pathogen (0)
- Guidelines (2)
- Tier Table (0)
- Synthesis (23)
No hay comentarios:
Publicar un comentario